The objective of this study is to evaluate the analgesic efficacy and safety of ADL5859 compared with placebo and an active control (ibuprofen) in subjects with acute dental pain after third molar extraction.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
201
SCIREX Research Center
Austin, Texas, United States
Total pain relief 0-4 hours after study medication
Time frame: 4 hours after study medication
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
single dose
single dose